United Arab Emirates, 12 June 2024 – NMC Healthcare Group (“NMC” or the “Company”), the leading integrated private healthcare provider in the United Arab Emirates (“UAE”), has announced the appointment of Rothschild & Co as the first of two Joint Financial Advisors. This selection marks the beginning of a comprehensive review of strategic alternatives for its shareholders, which could include a potential initial public offering (IPO), a sale of the business, or other strategic options. A second Financial Advisor will be appointed shortly.

The appointment of these Joint Financial Advisors follows several significant milestones achieved since the completion of NMC’s restructuring in March 2022.

These milestones include:
The successful restructuring of NMC and the subsequent exit from administration of NMC’s 34 core operating companies, overseen by the Abu Dhabi Global Market (“ADGM”) courts and in accordance with ADGM’s insolvency regulations.
The appointment of a new Board of Directors and the establishment of new Executive and Group leadership teams, led by CEO and regional healthcare leader David Hadley, to support NMC’s growth initiatives.
The appointment of PricewaterhouseCoopers Limited Partnership (registered in the Abu Dhabi Global Market) as NMC’s auditor.
The successful resolution of significant legacy creditor litigation.
The development and implementation of strategic business, growth, and digital transformation plans across the group.

NMC Healthcare, founded in 1975, is a network of 85 hospitals, specialty clinics, and medical facilities operating under the NMC, ProVita International Medical Centre, CosmeSurge, and Fakih IVF Fertility Centre brands. Serving over 5.5 million patients annually, NMC’s 12,000 employees are uniquely positioned to provide high-quality healthcare services across the UAE, including the three most populous Emirates—Abu Dhabi, Dubai, and Sharjah—as well as the Northern Emirates of Ras Al Khaimah and Ajman.

David Hadley, CEO of NMC Healthcare, commented, “We are pleased to explore strategic alternatives for the company at an exciting time in the UAE. The market is witnessing rapid population growth and presents an attractive opportunity to provide high-quality medical services across diverse and changing demographics. We are committed to delivering continued value to our stakeholders and the millions of patients we serve every year.”

As the review of strategic alternatives progresses, Rothschild & Co will also be responsible for responding to market inquiries on behalf of NMC Healthcare.

Contact Details:
Name: NMC Healthcare
Website: https://nmc.ae/en
Tel.: +97126332255
E-mail: [email protected]